A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age
Public ClinicalTrials.gov record NCT05044195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Observer-blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine in Comparison With a Licensed Quadrivalent Influenza Vaccine, in Adults 50 to 64 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 3 study is a randomized, observer-blind immunogenicity and safety study of aQIV (an MF59-adjuvanted quadrivalent influenza vaccine) compared with a licensed quadrivalent influenza vaccine in adults 50 to 64 years of age.
Study identification
- NCT ID
- NCT05044195
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,044 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2021
- Primary completion
- Jan 17, 2022
- Completion
- Sep 8, 2022
- Last update posted
- Sep 27, 2023
2021 – 2022
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 84013 Coastal Clinical Research, Inc. | Mobile | Alabama | 36608 | — |
| 84007 Alliance for Multispecialty Research | Tempe | Arizona | 85281 | — |
| 84005 JEM Research Institute | Atlantis | Florida | 33462 | — |
| 84010 Headlands Research Orlando | Orlando | Florida | 32819 | — |
| 84001 Meridian Clinical Research | Savannah | Georgia | 31406 | — |
| 84003 Meridian Clinical Research | Sioux City | Iowa | 51106 | — |
| 84006 Alliance for Multispecialty Research | Kansas City | Missouri | 64114 | — |
| 84009 Meridian Clinical Research | Lincoln | Nebraska | 68510 | — |
| 84002 Meridian Clinical Research | Norfolk | Nebraska | 68701 | — |
| 84004 Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| 84008 United Medical Associates | Binghamton | New York | 13901 | — |
| 84011 Meridian Clinical Research | Endwell | New York | 13760 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05044195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2023 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05044195 live on ClinicalTrials.gov.